Hanall Biopharma Co., Ltd. (KRX:009420)
South Korea · Delayed Price · Currency is KRW 46,800
+800 (1.74%)
Apr 8, 2026, 3:30 PM KST
Hanall Biopharma Market Cap
Hanall Biopharma has a market cap or net worth of 2.34 trillion as of April 8, 2026. Its market cap has increased by 32.99% in one year.
Market Cap
2.34T
Enterprise Value
2.34T
Revenue
155.18B
Ranking
n/a
PE Ratio
n/a
Stock Price
46,800.00
Market Cap Chart
Since August 30, 1995, Hanall Biopharma's market cap has increased from 26.30B to 2.34T, an increase of 8,782.06%. That is a compound annual growth rate of 15.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 2.34T | 5.14% |
| Dec 30, 2025 | 2.22T | 13.35% |
| Dec 30, 2024 | 1.96T | -12.72% |
| Dec 28, 2023 | 2.25T | 148.89% |
| Dec 29, 2022 | 902.29B | -16.29% |
| Dec 30, 2021 | 1.08T | -43.84% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Yuhan | 6.90T |
| Hanmi Pharm. | 6.43T |
| Celltrion Pharm | 2.37T |
| Daewoong Pharmaceutical | 1.79T |
| GC Biopharma | 1.60T |
| DongKook Pharmaceutical | 1.24T |
| Chong Kun Dang Pharmaceutical | 1.16T |
| Daewoong | 926.17B |